MTOR and hepatocellular carcinoma: In HepG2 cells, a human hepatoma cell line, AQP9 was found to be up-regulated by insulin through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling cascade.